Literature DB >> 33952604

International consensus to standardise histopathological scoring for small bowel strictures in Crohn's disease.

Ilyssa O Gordon1, Dominik Bettenworth2, Arne Bokemeyer2, Amitabh Srivastava3, Christophe Rosty4,5,6, Gert de Hertogh7, Marie E Robert8, Mark A Valasek9, Ren Mao10,11,12, Jiannan Li11, Noam Harpaz13, Paula Borralho14, Reetesh K Pai15, Robert Odze16, Roger Feakins17, Claire E Parker18, Leonardo Guizzetti18, Tran Nguyen18, Lisa M Shackelton18, William J Sandborn19, Vipul Jairath18,20, Mark Baker21, David Bruining22, Joel G Fletcher23, Brian G Feagan18,20, Rish K Pai24, Florian Rieder25,12.   

Abstract

OBJECTIVE: Effective medical therapy and validated trial outcomes are lacking for small bowel Crohn's disease (CD) strictures. Histopathology of surgically resected specimens is the gold standard for correlation with imaging techniques. However, no validated histopathological scoring systems are currently available for small bowel stricturing disease. We convened an expert panel to evaluate the appropriateness of histopathology scoring systems and items generated based on panel opinion.
DESIGN: Modified RAND/University of California Los Angeles methodology was used to determine the appropriateness of 313 candidate items related to assessment of CD small bowel strictures.
RESULTS: In this exercise, diagnosis of naïve and anastomotic strictures required increased bowel wall thickness, decreased luminal diameter or internal circumference, and fibrosis of the submucosa. Specific definitions for stricture features and technical sampling parameters were also identified. Histopathologically, a stricture was defined as increased thickness of all layers of the bowel wall, fibrosis of the submucosa and bowel wall, and muscularisation of the submucosa. Active mucosal inflammatory disease was defined as neutrophilic inflammation in the lamina propria and any crypt or intact surface epithelium, erosion, ulcer and fistula. Chronic mucosal inflammatory disease was defined as crypt architectural distortion and loss, pyloric gland metaplasia, Paneth cell hyperplasia, basal lymphoplasmacytosis, plasmacytosis and fibrosis, or prominent lymphoid aggregates at the mucosa/submucosa interface. None of the scoring systems used to assess CD strictures were considered appropriate for clinical trials.
CONCLUSION: Standardised assessment of gross pathology and histopathology of CD small bowel strictures will improve clinical trial efficiency and aid drug development. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  crohn's disease; fibrogenesis; fibrosis; histopathology

Mesh:

Year:  2021        PMID: 33952604      PMCID: PMC8903083          DOI: 10.1136/gutjnl-2021-324374

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

1.  Measuring health status: what are the necessary measurement properties?

Authors:  G H Guyatt; B Kirshner; R Jaeschke
Journal:  J Clin Epidemiol       Date:  1992-12       Impact factor: 6.437

2.  Development and validation of a histological index for UC.

Authors:  Mahmoud H Mosli; Brian G Feagan; Guangyong Zou; William J Sandborn; Geert D'Haens; Reena Khanna; Lisa M Shackelton; Christopher W Walker; Sigrid Nelson; Margaret K Vandervoort; Valerie Frisbie; Mark A Samaan; Vipul Jairath; David K Driman; Karel Geboes; Mark A Valasek; Rish K Pai; Gregory Y Lauwers; Robert Riddell; Larry W Stitt; Barrett G Levesque
Journal:  Gut       Date:  2015-10-16       Impact factor: 23.059

3.  Development and validation of the Nancy histological index for UC.

Authors:  Aude Marchal-Bressenot; Julia Salleron; Camille Boulagnon-Rombi; Claire Bastien; Virginie Cahn; Guillaume Cadiot; Marie-Danièle Diebold; Silvio Danese; Walter Reinisch; Stefan Schreiber; Simon Travis; Laurent Peyrin-Biroulet
Journal:  Gut       Date:  2015-10-13       Impact factor: 23.059

4.  An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease.

Authors:  F Rieder; D Bettenworth; C Ma; C E Parker; L A Williamson; S A Nelson; G van Assche; A Di Sabatino; Y Bouhnik; R W Stidham; A Dignass; G Rogler; S A Taylor; J Stoker; J Rimola; M E Baker; J G Fletcher; J Panes; W J Sandborn; B G Feagan; V Jairath
Journal:  Aliment Pharmacol Ther       Date:  2018-06-19       Impact factor: 8.171

Review 5.  Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease.

Authors:  David H Bruining; Ellen M Zimmermann; Edward V Loftus; William J Sandborn; Cary G Sauer; Scott A Strong
Journal:  Gastroenterology       Date:  2018-01-10       Impact factor: 22.682

6.  Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients.

Authors:  Javier Díez; Ramón Querejeta; Begoña López; Arantxa González; Mariano Larman; José L Martínez Ubago
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

7.  MR enterography-histology comparison in resected pediatric small bowel Crohn disease strictures: can imaging predict fibrosis?

Authors:  Daniel T Barkmeier; Jonathan R Dillman; Mahmoud Al-Hawary; Amer Heider; Matthew S Davenport; Ethan A Smith; Jeremy Adler
Journal:  Pediatr Radiol       Date:  2015-12-05

8.  Correlation of CT enteroclysis with surgical pathology in Crohn's disease.

Authors:  Michael V Chiorean; Kumar Sandrasegaran; Romil Saxena; Dean D Maglinte; Attila Nakeeb; Cynthia S Johnson
Journal:  Am J Gastroenterol       Date:  2007-09-26       Impact factor: 10.864

9.  Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients.

Authors:  Amgad E el-Agroudy; Nabil A Hassan; Mohamed A Foda; Amani M Ismail; Essam A el-Sawy; Omar Mousa; Mohamed A Ghoneim
Journal:  Am J Nephrol       Date:  2003-08-06       Impact factor: 3.754

10.  Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.

Authors:  Dominik Bettenworth; Florian Rieder
Journal:  Fibrogenesis Tissue Repair       Date:  2014-03-29
View more
  4 in total

Review 1.  Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis.

Authors:  Calen A Steiner; Ian M Cartwright; Cormac T Taylor; Sean P Colgan
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-01       Impact factor: 5.282

Review 2.  Intestinal strictures in Crohn's disease: a 2021 update.

Authors:  Xiaoxuan Lin; Yu Wang; Zishan Liu; Sinan Lin; Jinyu Tan; Jinshen He; Fan Hu; Xiaomin Wu; Subrata Ghosh; Minhu Chen; Fen Liu; Ren Mao
Journal:  Therap Adv Gastroenterol       Date:  2022-06-21       Impact factor: 4.802

3.  Biomechanical Properties of Strictures in Crohn's Disease: Can Dynamic Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography Predict Stiffness?

Authors:  Rune Wilkens; Dong-Hua Liao; Hans Gregersen; Henning Glerup; David A Peters; Charlotte Buchard; Anders Tøttrup; Klaus Krogh
Journal:  Diagnostics (Basel)       Date:  2022-06-02

4.  Diagnostic Accuracy of Magnetic Resonance Enterography for the Evaluation of Active and Fibrotic Inflammation in Crohn's Disease.

Authors:  Florian N Loch; Carsten Kamphues; Katharina Beyer; Frederick Klauschen; Christian Schineis; Benjamin Weixler; Johannes C Lauscher; Marc Dorenbeck; Christian Bayerl; Rolf Reiter
Journal:  Front Surg       Date:  2022-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.